6533b82ffe1ef96bd12950c1

RESEARCH PRODUCT

Characterization of Locally Excited and Charge-Transfer States of the Anticancer Drug Lapatinib by Ultrafast Spectroscopy and Computational Studies

Ignacio VayáConcepción González-belloM. Consuelo CuquerellaDaniel Roca-sanjuánEmilio LenceMiriam Navarrete-miguelImmaculada AndreuMiguel A. Miranda

subject

Femtosecond transient absorptionAntineoplastic AgentsSerum Albumin HumanMolecular Dynamics Simulation010402 general chemistryLapatinib01 natural sciencesAnticancer drugsCatalysisFluorescenceQUIMICA ORGANICAComputational chemistrymedicineHumansSpectroscopy010405 organic chemistryChemistryMolecular dynamics simulationsSpectrum AnalysisOrganic Chemistrydigestive oral and skin physiologyCharge (physics)LapatinibGeneral Chemistryequipment and suppliesAnticancer drug0104 chemical sciencesCharacterization (materials science)Excited stateUltrashort pulsehuman activitiesmedicine.drug

description

[EN] Lapatinib (LAP) is an anticancer drug, which is metabolized to theN- and O-dealkylated products (N-LAP andO-LAP, respectively). In view of the photosensitizing potential of related drugs, a complete experimental and theoretical study has been performed on LAP,N-LAP andO-LAP, both in solution and upon complexation with human serum albumin (HSA). In organic solvents, coplanar locally excited (LE) emissive states are generated; they rapidly evolve towards twisted intramolecular charge-transfer (ICT) states. By contrast, within HSA only LE states are detected. Accordingly, femtosecond transient absorption reveals a very fast switching (ca. 2 ps) from LE (lambda(max)=550 nm) to ICT states (lambda(max)=480 nm) in solution, whereas within HSA the LE species become stabilized and live much longer (up to the ns scale). Interestingly, molecular dynamics simulation studies confirm that the coplanar orientation is preferred for LAP (or to a lesser extentN-LAP) within HSA, explaining the experimental results.

10.1002/chem.202001336http://hdl.handle.net/10261/234062